A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR&lt;sup&gt;+&lt;/sup&gt; Breast Cancer. Here, CDK4 is linked to neoplasm.